Recently Isidori et al., showed a weight and HbA1c reduction and an improvement in QoL and infection rates in the group switched to the same dose of DR-HC after 24 weeks of follow-up period, providing a link between innate immunity, clock genes and physiological cortisol rhythm. This evidence concerns the gene CLOCK and infection.